UnitedHealth Group (NYSE:UNH) Price Target Cut to $362.00 by Analysts at Deutsche Bank Aktiengesellschaft

UnitedHealth Group (NYSE:UNH - Get Free Report) had its target price dropped by equities research analysts at Deutsche Bank Aktiengesellschaft from $521.00 to $362.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has a "buy" rating on the healthcare conglomerate's stock. Deutsche Bank Aktiengesellschaft's target price would suggest a potential upside of 16.68% from the company's current price.

A number of other equities analysts have also recently weighed in on the stock. Mizuho upped their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Truist Financial decreased their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research note on Monday, April 21st. JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Finally, Oppenheimer cut their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday. Six equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $523.52.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $1.12 during midday trading on Wednesday, reaching $310.26. 24,107,382 shares of the company were exchanged, compared to its average volume of 5,051,696. UnitedHealth Group has a 1 year low of $309.10 and a 1 year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a fifty day simple moving average of $482.53 and a 200 day simple moving average of $519.28. The stock has a market cap of $281.45 billion, a P/E ratio of 20.02, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the previous year, the company posted $6.91 EPS. On average, research analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Norinchukin Bank The lifted its position in UnitedHealth Group by 13.5% in the first quarter. Norinchukin Bank The now owns 59,444 shares of the healthcare conglomerate's stock valued at $31,134,000 after buying an additional 7,069 shares during the last quarter. CW Advisors LLC increased its stake in UnitedHealth Group by 44.3% during the first quarter. CW Advisors LLC now owns 31,136 shares of the healthcare conglomerate's stock worth $16,275,000 after purchasing an additional 9,564 shares during the period. Summit Financial LLC lifted its position in shares of UnitedHealth Group by 2.1% during the first quarter. Summit Financial LLC now owns 25,249 shares of the healthcare conglomerate's stock worth $13,224,000 after purchasing an additional 520 shares in the last quarter. Kaufman Rossin Wealth LLC acquired a new stake in shares of UnitedHealth Group during the first quarter worth about $438,000. Finally, PGIM Custom Harvest LLC lifted its position in shares of UnitedHealth Group by 47.8% during the first quarter. PGIM Custom Harvest LLC now owns 5,600 shares of the healthcare conglomerate's stock worth $2,933,000 after purchasing an additional 1,812 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.